Refine
Has Fulltext
- yes (36)
Is part of the Bibliography
- yes (36)
Year of publication
Document Type
- Journal article (36)
Language
- English (36)
Keywords
- cancer (10)
- oncolytic virus (6)
- oncolysis (5)
- vaccinia virus (5)
- Cancer (3)
- Nude-mice (3)
- Therapy (3)
- angiogenesis (3)
- breast-tumors (3)
- canine cancer therapy (3)
- therapy (3)
- virotherapy (3)
- Agent (2)
- Breast-tumors (2)
- GLV-1H68 (2)
- Lung cancer (2)
- VACV (2)
- adenovirus (2)
- blood (2)
- breast cancer (2)
- cancer treatment (2)
- canine cancer cell lines (2)
- canine soft tissue sarcoma (CSTS) (2)
- carcinoma (2)
- cell cultures (2)
- identification (2)
- metastasis (2)
- microenvironment (2)
- mouse models (2)
- nude-mice (2)
- oncolytic virotherapy (2)
- oncolytic viruses (2)
- reporter gene (2)
- viral replication (2)
- BV-2 (1)
- Biochemie (1)
- Biologie (1)
- Blood-brain barrier (1)
- CD9 (1)
- COX-2 (1)
- Carcinoma (1)
- Chemotherapy (1)
- Combination therapy (1)
- Cyclophosphamide (1)
- Deletion (1)
- Escherichia coli (1)
- Expression (1)
- GBM (1)
- GI-101A tumor xenografts (1)
- Gene-expression (1)
- Human Sodium/Iodide symporter (1)
- IMA2.1 (1)
- In-Vivo (1)
- In-vivo (1)
- IncuCyte\(^®\)S3 (1)
- Inhibitor (1)
- Iron-uptake (1)
- Krebs <Medizin> (1)
- Lungenkrebs (1)
- MDSCs (1)
- MRI reporter (1)
- Malignant effusion (1)
- Medizin (1)
- Mice (1)
- NA+/I-symporter (1)
- NA/I symporter (1)
- NO (1)
- OSC (1)
- Oncolytic vaccinia virus (1)
- Oncolytic virotherapy (1)
- Protein (1)
- Proteins (1)
- Recombinant vaccinia (1)
- Regression (1)
- Reporter gene (1)
- Salmonella-typhimurium (1)
- Sugar-transport (1)
- Tissue (1)
- Transporter (1)
- VEGF (1)
- Vaccinia virus (1)
- Vascular endothelial Growth Factor (1)
- Virusinfektion (1)
- acute myeloid leukemia (1)
- animal-model (1)
- antibodies (1)
- antibody production (1)
- antitumor immune response (1)
- antiviral immunity (1)
- ascites (1)
- biochemistry (1)
- biomarkers (1)
- bone morphogenetic protein (BMP) (1)
- boolean modeling (1)
- cancer stem cells (CSCs) and differentiation (1)
- cancer therapy (1)
- canine adipose-derived mesenchymal stem cells (cAdMSCs) (1)
- canine and feline cancer therapy (1)
- carcinomas (1)
- cell-line (1)
- chemotherapy (1)
- clinical trial (1)
- colorectal (1)
- combination therapy (1)
- conservation (1)
- conserving surgery (1)
- cytokine (1)
- cytolysis (1)
- dogs (1)
- endothelial growth-factor (1)
- engineered measles-virus (1)
- enzyme-linked immunoassays (1)
- epithelial-mesenchymal transition (1)
- fluorescence imaging (1)
- fluorescence microscopy (1)
- fluorescent recombinant vaccinia virus (1)
- gene expression (1)
- gene-therapy (1)
- glioblastoma multiforme (GBM) (1)
- glv-1h68 (1)
- histology (1)
- human xenografted mouse models (1)
- humanized tumor (1)
- hyper-IL-6 (1)
- iNOS (1)
- immunity (1)
- immunotherapy (1)
- immunotherapy of cancer (1)
- in vivo imaging (1)
- in-vitro (1)
- in-vitro propagation (1)
- infection (1)
- inflammation (1)
- innate immune system (1)
- lines (1)
- luciferase (1)
- lymph nodes (1)
- macrophages (1)
- magnetic resonance imaging (1)
- malignant pleural mesothelioma (1)
- mastectomy (1)
- matrix metalloproteinases (1)
- metastases (1)
- metastatic tumors (1)
- mice (1)
- microglia (1)
- microvascular density (1)
- model (1)
- modulation of virus replication (1)
- molecular imaging (1)
- mouse model (1)
- neutrophils (1)
- nude mice (1)
- oncolytic vaccinia virus (1)
- oncolytic virus therapy (1)
- pancreatic cancer (1)
- panel (1)
- pet dogs (1)
- plaque assay (1)
- plaque isolation (1)
- polarization (1)
- positron-emission-tomography (1)
- prostate (1)
- prostate cancer (1)
- radiation-therapy (1)
- receptor (1)
- replicating adenovirus (1)
- sodium-iodide symporter (1)
- stage-i (1)
- stem Cells (1)
- stromal vascular fraction (1)
- subcutaneous human tumors (1)
- subpopulation (1)
- target molecule (1)
- thyroid-cancer (1)
- tumor microenvironment (1)
- tumors (1)
- vaccinia (1)
- vaccinia virus (VACV) (1)
- viral therapy (1)
Institute
- Lehrstuhl für Biochemie (27)
- Rudolf-Virchow-Zentrum (13)
- Institut für Molekulare Infektionsbiologie (12)
- Theodor-Boveri-Institut für Biowissenschaften (7)
- Physikalisches Institut (3)
- Institut für Medizinische Strahlenkunde und Zellforschung (1)
- Julius-von-Sachs-Institut für Biowissenschaften (1)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (1)
- Medizinische Klinik und Poliklinik I (1)
Background:
Oncolytic viral therapy represents an alternative therapeutic strategy for the treatment of cancer. We previously described GLV-1h68, a modified Vaccinia Virus with exclusive tropism for tumor cells, and we observed a cell line-specific relationship between the ability of GLV-1h68 to replicate in vitro and its ability to colonize and eliminate tumor in vivo.
Methods:
In the current study we surveyed the in vitro permissivity to GLV-1h68 replication of the NCI-60 panel of cell lines. Selected cell lines were also tested for permissivity to another Vaccinia Virus and a vesicular stomatitis virus (VSV) strain. In order to identify correlates of permissity to viral infection, we measured transcriptional profiles of the cell lines prior infection.
Results:
We observed highly heterogeneous permissivity to VACV infection amongst the cell lines. The heterogeneity of permissivity was independent of tissue with the exception of B cell derivation. Cell lines were also tested for permissivity to another Vaccinia Virus and a vesicular stomatitis virus (VSV) strain and a significant correlation was found suggesting a common permissive phenotype. While no clear transcriptional pattern could be identified as predictor of permissivity to infection, some associations were observed suggesting multifactorial basis permissivity to viral infection.
Conclusions:
Our findings have implications for the design of oncolytic therapies for cancer and offer insights into the nature of permissivity of tumor cells to viral infection.